Advertisement
Advertisement

ACIU

ACIU logo

AC Immune SA

2.32
USD
Sponsored
+0.09
+4.04%
Jul 27, 13:45 UTC -4
Open

ACIU Earnings Reports

Positive Surprise Ratio

ACIU beat 23 of 38 last estimates.

61%

Next Report

In 3 Days
Date of Next Report
Jul 30, 2026
Estimate for Q2 26 (Revenue/ EPS)
$6.84M
/
-$0.11
Implied change from Q1 26 (Revenue/ EPS)
+511.03%
/
-26.67%
Implied change from Q2 25 (Revenue/ EPS)
+423.54%
/
-47.62%

AC Immune SA earnings per share and revenue

On Apr 30, 2026, ACIU reported earnings of -0.15 USD per share (EPS) for Q1 26, beating the estimate of -0.15 USD, resulting in a 3.29% surprise. Revenue reached 1.12 million, compared to an expected 275.47 thousand, with a 306.21% difference. The market reacted with a +3.41% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.11 USD, with revenue projected to reach 6.84 million USD, implying an decrease of -26.67% EPS, and increase of 511.03% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
NovoCure Limited Ordinary Shares
Report Date
Jul 23, 2026 For Q2 26
Estimate
-$0.33
Actual
-$0.13
Surprise
+61.70%
logo
DBV Technologies S.A.
Report Date
Jul 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.60
Surprise
-494.06%
logo
argenx SE - ADR
Report Date
Jul 23, 2026 For Q2 26
Estimate
$6.29
Actual
$7.32
Surprise
+16.38%
logo
Lexaria Bioscience Corp. Common Stock
Report Date
Jul 13, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+7.73%
logo
VivoSim Labs, Inc. Common Stock
Report Date
Jul 14, 2026 For Q4 25
Estimate
-$0.19
Actual
-$2.21
Surprise
-1,040.35%
FAQ
For Q1 2026, AC Immune SA reported EPS of -$0.15, beating estimates by 3.29%, and revenue of $1.12M, 306.21% above expectations.
The stock price moved up 3.41%, changed from $2.93 before the earnings release to $3.03 the day after.
The next earning report is scheduled for Jul 30, 2026.
Based on -- analysts, AC Immune SA is expected to report EPS of -$0.11 and revenue of $6.84M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement